Literature DB >> 15986327

Cerebral embolic protection.

Mark K Eskandari1.   

Abstract

Carotid angioplasty and stenting (CAS) is rapidly evolving into a viable alternative to carotid endarterectomy (CEA). This has been possible due to advances in endoluminal equipment and the development of mechanical cerebral embolic protection devices. Theoretically, these various devices reduce the occurrence of distal embolization into the intracranial circulation and thereby minimize the clinical consequence of a cerebrovascular accident. Embolic protection systems are currently classified into three main categories depending on the mechanism: 1) distal occlusion; 2) distal filtration; and 3) proximal occlusion. This review will provide a framework with regard to these devices with some specific examples cited.

Entities:  

Mesh:

Year:  2005        PMID: 15986327     DOI: 10.1053/j.semvascsurg.2005.04.006

Source DB:  PubMed          Journal:  Semin Vasc Surg        ISSN: 0895-7967            Impact factor:   1.000


  4 in total

1.  Non-invasive embolus trap using histotripsy-an acoustic parameter study.

Authors:  Simone Park; Adam D Maxwell; Gabe E Owens; Hitinder S Gurm; Charles A Cain; Zhen Xu
Journal:  Ultrasound Med Biol       Date:  2013-02-13       Impact factor: 2.998

2.  Therapeutic ultrasound to noninvasively create intracardiac communications in an intact animal model.

Authors:  Gabe E Owens; Ryan M Miller; Greg Ensing; Kimberly Ives; David Gordon; Achi Ludomirsky; Zhen Xu
Journal:  Catheter Cardiovasc Interv       Date:  2010-10-12       Impact factor: 2.692

3.  Noninvasive thrombolysis using histotripsy beyond the intrinsic threshold (microtripsy).

Authors:  Xi Zhang; Gabe E Owens; Hitinder S Gurm; Yu Ding; Charles A Cain; Zhen Xu
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  2015-07       Impact factor: 2.725

4.  Noninvasive creation of an atrial septal defect by histotripsy in a canine model.

Authors:  Zhen Xu; Gabe Owens; David Gordon; Charles Cain; Achi Ludomirsky
Journal:  Circulation       Date:  2010-02-01       Impact factor: 29.690

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.